Literature DB >> 15446771

Readmission rate as an indicator of hospital performance: the case of Spain.

Alberto Jiménez-Puente1, Javier García-Alegría, Jorge Gómez-Aracena, Luis Hidalgo-Rojas, Luisa Lorenzo-Nogueiras, Emilio Perea-Milla-López, Joaquín Fernández-Crehuet-Navajas.   

Abstract

OBJECTIVES: Hospital readmission rate is currently used as a quality of care indicator, although its validity has not been established. Our aims were to identify the frequency and characteristics of potential avoidable readmissions and to compare the assessment of quality of care derived from readmission rate with other measure of quality (judgment of experts).
DESIGN: cross-sectional observational study;
SETTING: acute care hospital located in Marbella, South of Spain; STUDY PARTICIPANTS: random sample of patients readmitted at the hospital within six months from discharge (n = 363);
INTERVENTIONS: review of clinical records by a pair of observers to assess the causes of readmissions and their potential avoidability; MAIN MEASURES: logistic regression analysis to identify the variables from the databases of hospital discharges which are related to avoidability of readmissions. Determination of sensitivity and specificity of different definitions of readmission rate to detect avoidable situations.
RESULTS: Nineteen percent of readmissions were considered potentially avoidable. Variables related to readmission avoidability were (i) time elapsed between index admission and readmission and (ii) difference in diagnoses of both episodes. None of the definitions of readmission rate used in this study provided adequate values of sensitivity and specificity in the identification of potentially avoidable readmissions.
CONCLUSIONS: Most readmissions in our hospital were unavoidable. Thus, readmission rate might not be considered a valid indicator of quality of care.

Entities:  

Mesh:

Year:  2004        PMID: 15446771     DOI: 10.1017/s0266462304001230

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  8 in total

Review 1.  Proportion of hospital readmissions deemed avoidable: a systematic review.

Authors:  Carl van Walraven; Carol Bennett; Alison Jennings; Peter C Austin; Alan J Forster
Journal:  CMAJ       Date:  2011-03-28       Impact factor: 8.262

2.  CORR Insights (®): Are There Modifiable Risk Factors for Hospital Readmission After Total Hip Arthroplasty in a US Healthcare System?

Authors:  Ville Remes
Journal:  Clin Orthop Relat Res       Date:  2015-05-21       Impact factor: 4.176

3.  Predictors and Cost of Readmission in Total Knee Arthroplasty.

Authors:  Kenneth L Urish; Yongmei Qin; Benjamin Y Li; Tudor Borza; Michael Sessine; Peter Kirk; Brent K Hollenbeck; Jonathan E Helm; Mariel S Lavieri; Ted A Skolarus; Bruce L Jacobs
Journal:  J Arthroplasty       Date:  2018-04-17       Impact factor: 4.757

4.  Unplanned general surgical re-admissions - how many, which patients and why?

Authors:  Dayo Adeyemo; Simon Radley
Journal:  Ann R Coll Surg Engl       Date:  2007-05       Impact factor: 1.891

Review 5.  Is the readmission rate a valid quality indicator? A review of the evidence.

Authors:  Claudia Fischer; Hester F Lingsma; Perla J Marang-van de Mheen; Dionne S Kringos; Niek S Klazinga; Ewout W Steyerberg
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

6.  Hospital volume affects outcome after total knee arthroplasty.

Authors:  Konsta J Pamilo; Mikko Peltola; Juha Paloneva; Keijo Mäkelä; Unto Häkkinen; Ville Remes
Journal:  Acta Orthop       Date:  2014-10-17       Impact factor: 3.717

7.  The impact of hospital support function centralization on patient outcomes: A before-after study.

Authors:  Adrien Le Guillou; Jan Chrusciel; Stephane Sanchez
Journal:  Public Health Pract (Oxf)       Date:  2021-08-06

8.  Hospital readmission prevalence and analysis of those potentially avoidable in southern Italy.

Authors:  Aida Bianco; Antonio Molè; Carmelo G A Nobile; Gabriella Di Giuseppe; Claudia Pileggi; Italo F Angelillo
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.